icon-folder.gif   Conference Reports for NATAP  
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
"Treatment of Genotype 3 Cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: Real life experience from Italy"
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Luisa Pasulo on behalf Italian Real life HCV cirrhotic G3 Study Group (Navigatore Lombardy and Veneto, Piemonte, Tuscany, Sicily) E-mail: lpasulo@asst-pg23.it